Moors & Cabot, Inc. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 59 filers reported holding CASI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2018$187,000
+94.8%
22,9350.0%0.02%
+92.3%
Q1 2018$96,000
+17.1%
22,935
-7.0%
0.01%
+18.2%
Q4 2017$82,000
+70.8%
24,663
-5.3%
0.01%
+57.1%
Q3 2017$48,000
+77.8%
26,0530.0%0.01%
+75.0%
Q2 2017$27,000
-28.9%
26,0530.0%0.00%
-33.3%
Q1 2017$38,000
-58.7%
26,053
-67.2%
0.01%
-60.0%
Q4 2016$92,000
-1.1%
79,486
-5.5%
0.02%
-6.2%
Q3 2016$93,000
-8.8%
84,148
-0.5%
0.02%
-11.1%
Q2 2016$102,000
+22.9%
84,609
+7.8%
0.02%
+20.0%
Q1 2016$83,000
+40.7%
78,456
+21.7%
0.02%
+36.4%
Q4 2015$59,000
-32.2%
64,476
-21.8%
0.01%
-31.2%
Q3 2015$87,000
-46.3%
82,402
-6.5%
0.02%
-38.5%
Q2 2015$162,000
+25.6%
88,155
-2.3%
0.03%
+18.2%
Q1 2015$129,000
-2.3%
90,214
-8.9%
0.02%0.0%
Q4 2014$132,000
-24.6%
98,996
+3.4%
0.02%
-26.7%
Q3 2014$175,00095,6960.03%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders